期刊文献+

Mutant amyloid precursor protein and presenilin-1 genes effect on ischemia vulnerability via calcium homeostasis disturbance

Mutant amyloid precursor protein and presenilin-1 genes effect on ischemia vulnerability via calcium homeostasis disturbance
下载PDF
导出
摘要 BACKGROUND: Previous studies have demonstrated that mutant amyloid precursor protein (APP) or presenilin-1 (PS1) genes increase susceptibility to ischemic brain damage induced by middle cerebral artery occlusion. Possible mechanisms include over-production of beta-amyloid peptide (Aβ). OBJECTIVE: Because Aβ is over-produced in the APP/PS1 double-transgenic mouse, the present study focused on mechanisms of increased ischemic damage due to mutant APP and PS1 genes by measuring oxidative stress, mitochondrial function, and calcium homeostasis. DESIGN, TIME AND SETTING: The non-randomized, controlled, in vivo and in vitro experiments were performed at the Medical Research Center, Second Clinical College, Jinan University between May and October 2008. MATERIALS: Male APP transgenic mice carrying the mutant 695swe gene and female PS1 transgenic mice carrying the mutant Leu235Pro gene were donated from the University of Hong Kong. SHSY5Y human neureblastoma cells were purchased from ATCC (Manassas, VA, USA), and Aβ1-42 was obtained from Sigma-Aldrich (St. Louis, MO, USA). METHODS: APP transgenic mice were mated with PS1 transgenic mice to produce APP/PS1 double-transgenic mice and wildtype littermates mice. The photothrombotic stroke model was induced in six APP/PS1 double-transgenic and 6 wildtype littermates mice. SHSY5Y human neuroblastoma cells were cultured in vitro, and were divided into 4 groups: Aβ group, cells were exposed to 5 pmol/L Aβ for 24 hours; oxygen-glucose deprivation (OGD) group, cells were exposed to OGD for 1 hour after treatment with sterile, ultra-pure water for 24 hours; OGD+Aβ group, cells were exposed to OGD and Aβfor 1 hour after treatment with 5 pmol/L Aβ for 24 hours; sham control group: cells were exposed to sterile, ultra-pure water for 25 hours. OGD was achieved by exposing the cells to glucose-free DMEM and placing the cells in an anaerobic chamber flushed with 5% CO2 and 95% N2 (v/v) at 37 ℃ for 1 hour. MAIN OUTCOME MEASURES: TTC staining was used to measure infarct volume 7 days after photothrombotic stroke. Cell viability was evaluated using the MTT kit. Opening of the mitochondrial permeability transition pore, intracellular concentration of superoxide anion, and calcium after OGD were detected with fluorescence intensity of calcein-AM, hydroethidine, and fluo-3/AM. RESULTS: At 7 days after stroke, total infarct volume and cortical infarct volume were significantly greater in the APP/PS1 transgenic mice compared with the wildtype littermates mice (P 〈 0.01). Aβ, OGD, and Aβ + OGD significantly decreased cell viability and increased fluorescence intensity of hydroethidine and fluo-3/AM (P 〈 0.01). Compared with the Aβ or OGD group, Aβ + OGD significantly decreased cell viability (P 〈 0.01) and significantly increased fluorescence intensity of calcein-AM, hydroethidine, and fluo-3/AM (P 〈 0.01 or P 〈 0.05). CONCLUSION: The APP/PS1 double-transgenic mice were more vulnerable to ischemia. The possible mechanisms included enhanced opening of the mitochondrial permeability transition pore, overproduction of superoxide anion due to pore opening, and disturbed calcium homeostasis induced by excess superoxide anion. BACKGROUND: Previous studies have demonstrated that mutant amyloid precursor protein (APP) or presenilin-1 (PS1) genes increase susceptibility to ischemic brain damage induced by middle cerebral artery occlusion. Possible mechanisms include over-production of beta-amyloid peptide (Aβ). OBJECTIVE: Because Aβ is over-produced in the APP/PS1 double-transgenic mouse, the present study focused on mechanisms of increased ischemic damage due to mutant APP and PS1 genes by measuring oxidative stress, mitochondrial function, and calcium homeostasis. DESIGN, TIME AND SETTING: The non-randomized, controlled, in vivo and in vitro experiments were performed at the Medical Research Center, Second Clinical College, Jinan University between May and October 2008. MATERIALS: Male APP transgenic mice carrying the mutant 695swe gene and female PS1 transgenic mice carrying the mutant Leu235Pro gene were donated from the University of Hong Kong. SHSY5Y human neureblastoma cells were purchased from ATCC (Manassas, VA, USA), and Aβ1-42 was obtained from Sigma-Aldrich (St. Louis, MO, USA). METHODS: APP transgenic mice were mated with PS1 transgenic mice to produce APP/PS1 double-transgenic mice and wildtype littermates mice. The photothrombotic stroke model was induced in six APP/PS1 double-transgenic and 6 wildtype littermates mice. SHSY5Y human neuroblastoma cells were cultured in vitro, and were divided into 4 groups: Aβ group, cells were exposed to 5 pmol/L Aβ for 24 hours; oxygen-glucose deprivation (OGD) group, cells were exposed to OGD for 1 hour after treatment with sterile, ultra-pure water for 24 hours; OGD+Aβ group, cells were exposed to OGD and Aβfor 1 hour after treatment with 5 pmol/L Aβ for 24 hours; sham control group: cells were exposed to sterile, ultra-pure water for 25 hours. OGD was achieved by exposing the cells to glucose-free DMEM and placing the cells in an anaerobic chamber flushed with 5% CO2 and 95% N2 (v/v) at 37 ℃ for 1 hour. MAIN OUTCOME MEASURES: TTC staining was used to measure infarct volume 7 days after photothrombotic stroke. Cell viability was evaluated using the MTT kit. Opening of the mitochondrial permeability transition pore, intracellular concentration of superoxide anion, and calcium after OGD were detected with fluorescence intensity of calcein-AM, hydroethidine, and fluo-3/AM. RESULTS: At 7 days after stroke, total infarct volume and cortical infarct volume were significantly greater in the APP/PS1 transgenic mice compared with the wildtype littermates mice (P 〈 0.01). Aβ, OGD, and Aβ + OGD significantly decreased cell viability and increased fluorescence intensity of hydroethidine and fluo-3/AM (P 〈 0.01). Compared with the Aβ or OGD group, Aβ + OGD significantly decreased cell viability (P 〈 0.01) and significantly increased fluorescence intensity of calcein-AM, hydroethidine, and fluo-3/AM (P 〈 0.01 or P 〈 0.05). CONCLUSION: The APP/PS1 double-transgenic mice were more vulnerable to ischemia. The possible mechanisms included enhanced opening of the mitochondrial permeability transition pore, overproduction of superoxide anion due to pore opening, and disturbed calcium homeostasis induced by excess superoxide anion.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2009年第12期1049-1054,共6页 中国神经再生研究(英文版)
基金 Supported by: Shenzhen Science Technology Project from Shenzhen Bureau of Science Technology and Information, No. 200702029 Medicial Science Technology Research Fund of Guangdong Province, No. A2008601 & A2007570
关键词 amyloid precursor protein PRESENILIN-1 cerebral ischemia calcium d amyloid precursor protein presenilin-1 cerebral ischemia calcium d
  • 相关文献

参考文献31

  • 1Kamat CD, Gadal S, Mhatre M, et al. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis. 2008;15(3):473-493.
  • 2Castellani RJ. Vascular dementia and Alzheimer's disease: a waning dichotomy. J Alzheimers Dis. 2007;12(4):343-344.
  • 3Cole SL, Vassar R. The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. J Biol Chem. 2008;283(44):29621-29625.
  • 4Nathalie P, Jean-Noel O. Processing of amyloid precursor protein and amyloid peptide neurotoxicity. Curr Alzheimer Res. 2008;5(2): 92-99.
  • 5Kurata T, Kawarabayashi T, Murakami T, et al. Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1. J Neurosci Res. 2007;85(10):2246-2252.
  • 6Ancolio K, Marambaud P, Dauch P, et al. Alpha-secretase-dedved product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J Neurochem. 1997;69(6):2494-2499.
  • 7Koistinaho M, Kettunen MI, Goldsteins G, et al. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc Natl Acad Sci U S A. 2002;99(3):1610-1615.
  • 8Zhang F, Eckman C, Younkin S, et al. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J Neurosci. 1997;17(20):7655-7661.
  • 9Schroeter M, Jander S, Stoll G. Non-invasive induction of focal cerebral ischemia in mice by photothrombosis of cortical microvessels: characterization of inflammatory responses. J Neurosci Methods. 2002; 117(1 ):43-49.
  • 10The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部